IONS
Eplontersen Phase 3 results published in JAMA show consistent and sustained benefit
Thursday, September 28, 2023 1 min read
Key Takeaway: Eplontersen Phase 3 results published in JAMA show consistent and sustained benefit
Full Press Release Details
Eplontersen Phase 3 results published in JAMA show consistent and sustained benefit.